Junius Daniel M's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Dec 7, 2022
- Accession no.
- 0001567619-22-021390
- Filed
- Dec 7, 2022
- Trade date
- Dec 5, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.29M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Junius Daniel MCIK 0001094159 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2022 | Common Stock | MOption exerciseAcquired | +3,046 | $160.28 | +$488,212.88 | 6,014 | Direct | |
| Dec 5, 2022 | Common Stock | SSaleDisposed | −3,046 | $424.91 | −$1,294,275.86 | 2,968 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2022 | Common Stock | MOption exerciseDisposed | −3,046 | –F2 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Not applicable.
Referenced by the price of 1 transaction in Table II.